BIOMAT Database Logo BIOMAT Database Logo

Specific therapeutic actions of acetophenazine, perphenazine, and benzquinamide in newly admitted schizophrenic patients. 1967

L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010546 Perphenazine An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE. Chlorpiprazine,Perfenazine,Trilafon
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D011804 Quinolines
D011807 Quinolizines
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
The therapeutic index of haloperidol in newly admitted schizophrenic patients.
January 1987, Psychopharmacology bulletin,
L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.
January 1966, Psychopharmacologia,
L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
Drug treatment in newly admitted schizophrenic patients.
November 1971, Archives of general psychiatry,
L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
Homocysteine levels in newly admitted schizophrenic patients.
January 2004, Journal of psychiatric research,
L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
Loxapine in newly admitted chronic schizophrenic patients.
April 1975, Journal of clinical pharmacology,
L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients.
November 1966, Current therapeutic research, clinical and experimental,
L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
Pimozide in the treatment of newly admitted schizophrenic patients.
January 1982, Psychopharmacology,
L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
Acetophenazine in ambulatory schizophrenic adults.
September 1962, The American journal of psychiatry,
L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
Paranoid/belligerence and neuroleptic dosage in newly admitted schizophrenic patients.
April 1997, Journal of clinical psychopharmacology,
L E Hollister, and J E Overall, and J L Bennett, and I Kimbell, and J Shelton
Clinical evaluation of thiothixene in acute newly admitted schizophrenic patients.
August 1971, Singapore medical journal,
Copied contents to your clipboard!